101 related articles for article (PubMed ID: 8652383)
1. Molecular alterations of IL-6R, lck and c-myc genes in transforming monoclonal gammopathies of undetermined significance.
Gernone A; Dammacco F
Br J Haematol; 1996 Jun; 93(3):623-31. PubMed ID: 8652383
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells.
Nobuyoshi M; Kawano M; Tanaka H; Ishikawa H; Tanabe O; Iwato K; Asaoku H; Sakai A; Kuramoto A
Br J Haematol; 1991 Apr; 77(4):523-8. PubMed ID: 2025578
[TBL] [Abstract][Full Text] [Related]
3. [Determination of interleukin-6 messenger RNA as malignant progression index in monoclonal gammapathy of undetermined significance].
Mancini R; Palange M; Dionisi MG; De Angelis V; Matteocci A; Strano L
Recenti Prog Med; 1999 Oct; 90(10):522-6. PubMed ID: 10592737
[TBL] [Abstract][Full Text] [Related]
4. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma.
Chim CS; Liang R; Leung MH; Kwong YL
J Clin Pathol; 2007 Jan; 60(1):104-6. PubMed ID: 17213358
[TBL] [Abstract][Full Text] [Related]
5. [IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias].
Alvino S; Marcucci M; Canzoniere D; Mosiello A; Del Monte G; Venturo I; Rinaldi M; Gandolfo GM; Lopez M; Greco C
Clin Ter; 1999; 150(3):197-202. PubMed ID: 10528431
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component.
Greco C; Ameglio F; Alvino F; Mosiello A; Cianciulli AM; Venturo I; Del Monte G; Giampaolo M; Tong AW; Gandolfo GM
Cell Prolif; 1999 Aug; 32(4):231-8. PubMed ID: 10614712
[TBL] [Abstract][Full Text] [Related]
7. The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma.
Fiedler W; Weh HJ; Suciu E; Wittlief C; Stocking C; Hossfeld DK
Leukemia; 1990 Jul; 4(7):462-5. PubMed ID: 1695702
[TBL] [Abstract][Full Text] [Related]
8. [Immunoglobulin heavy chain gene rearrangements in the monoclonal gammopathies].
Bosaleh A; Denninghoff V; Garcia A; Rescia C; Avagnina A; Elsner B
Medicina (B Aires); 2005; 65(3):219-25. PubMed ID: 16042132
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of serum IL-6 level in monoclonal gammopathies.
DuVillard L; Guiguet M; Casasnovas RO; Caillot D; Monnier-Zeller V; Bernard A; Guy H; Solary E
Br J Haematol; 1995 Feb; 89(2):243-9. PubMed ID: 7873373
[TBL] [Abstract][Full Text] [Related]
10. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
[TBL] [Abstract][Full Text] [Related]
11. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
Martín P; Santón A; García-Cosío M; Bellas C
Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
[TBL] [Abstract][Full Text] [Related]
12. Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.
Greipp PR; Lust JA
Stem Cells; 1995 Aug; 13 Suppl 2():10-21. PubMed ID: 8520496
[TBL] [Abstract][Full Text] [Related]
13. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma.
Affer M; Chesi M; Chen WG; Keats JJ; Demchenko YN; Roschke AV; Van Wier S; Fonseca R; Bergsagel PL; Kuehl WM
Leukemia; 2014 Aug; 28(8):1725-1735. PubMed ID: 24518206
[TBL] [Abstract][Full Text] [Related]
14. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
[TBL] [Abstract][Full Text] [Related]
15. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
[TBL] [Abstract][Full Text] [Related]
16. RAS gene mutations in multiple myeloma and related monoclonal gammopathies.
Matozaki S; Nakagawa T; Nakao Y; Fujita T
Kobe J Med Sci; 1991 Feb; 37(1):35-45. PubMed ID: 1921261
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance.
Bernasconi P; Cavigliano PM; Boni M; Astori C; Calatroni S; Giardini I; Rocca B; Caresana M; Crosetto N; Lazzarino M; Bernasconi C
Br J Haematol; 2002 Aug; 118(2):545-9. PubMed ID: 12139743
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
